Pillstats
Rx only · Tablet, Film Coated · Oral

Hydroxyurea

Brands: Siklos · Hydroxyurea

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)5552
US makers1 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$9.81$19.62$29.43$39.24Jan 2026Jul 2026Jul 2026
$34.123
Latest avg · Jul 22, 2026
+0%
Since Jan 1, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.8K4.3K5.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.0K
Rx · 2026 Q1
320K
Units dispensed
+16%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Medunik USAunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.